Loading
A phase 1 trial of DNX-2401 run by M.D. Anderson Cancer Center, now recruiting.
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases is a phase 1 interventional study registered as NCT07444606 by M.D. Anderson Cancer Center, with 50 participants planned, started 2026-09-25. Conditions recorded: Melanoma. Interventions recorded: DNX-2401.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/